For early Lyme disease, 10 days of therapy are as good as 20

May 05, 2003

PHILADELPHIA -- (May 5, 2003) A study of 180 people diagnosed with early, uncomplicated Lyme disease (a rash without joint or nerve symptoms) found that a 10-day course of the antibiotic doxycycline was as effective as a 20-day course. Physicians generally prescribe between 10 and 21 days of the antibiotic for early Lyme disease; the number of days appears to be increasing. The study is published in the May 6, 2003, issue of Annals of Internal Medicine.

"Shorter courses of treatment are safer, less expensive, and may be less likely to promote emergence of resistant bacteria that can endanger the entire community," said Gary P. Wormser, MD, of New York Medical College in Valhalla, N.Y., lead author of the study.

The randomized trial assigned patients to three groups. One got either a single intravenous dose of an antibiotic (ceftriaxone) followed by 10 days of antibiotic pills (doxycycline twice daily) and then 10 more days of dummy pills (placebo twice daily). Another received intravenous sugar water, as a placebo, followed by 10 days of doxycycline pills and then 10 days of placebo pills. The third received intravenous placebo fluid followed by 20 days of doxycycline pills.

"Most patients responded similarly to either the 10-day or 20-day cycle," said Wormser. "The study suggests that people with early Lyme disease and no heart, joint or neurologic abnormalities, such as meningitis, can usually be treated successfully with 10 days of antibiotic therapy."

Approximately two-thirds of patients in each group had a complete response at 20 days, and more than 80 percent of all patients had a complete response at 30 months.

"Similar results were found in 49 patients with erythema migrans (the hallmark red rash caused by Lyme disease) who received 10 or 20 days of tetracycline, a drug related to doxycycline, as reported in Annals of Internal Medicine in 1980," said Allen C. Steere, MD, one of the discoverers of Lyme disease in 1975 and a well-known researcher on the disease since. "However, the study published in Annals today demonstrated this fairly conclusively in a larger number of patients."

In an accompanying editorial, Steere says, "In brief, Lyme disease can usually be treated successfully with oral doxycycline or amoxicillin, except for patients with objective neurologic abnormalities. Ten days of doxycycline therapy is usually enough for patients with the erythema migrans rash. With such treatment, most patients have satisfactory outcomes."
-end-
ACP (Internal Medicine. Doctors for Adults ®), publisher of Annals of Internal Medicine, is the second-largest physician group in the United States. Membership includes internists, related subspecialists, and medical students. Internists specialize in the prevention, detection and treatment of illnesses in adults.

NOTES TO EDITOR:

Copies of the embargoed article, "Duration of Antibiotic Therapy for Early Lyme Disease," and the editorial, "Duration of Antibiotic Therapy for Lyme Disease," are available by calling 800-523-1546, ext. 2656 or 215-351-2656.

Dr. Wormser is chief of infectious diseases at New York Medical College and Westchester Medical Center. For an interview, call Donna Moriarty, New York Medical College Office of Public Relations, 914-594-4536.

Clay Heydorn, a patient with Lyme disease who participated in the Wormser study and was successfully treated with a 10-day course of antibiotics, is available for interview. Call Donna Moriarty, New York Medical College Office of Public Relations, 914-594-4536.

This article is the subject of a video news release. Coordinate: Monday, May 5, first feed: 09:00-09:30 AM EDT; second feed: 14:00-14:30 PM EDT (2-2:30 p.m.) Telestar 6, Transponder 11 [C] Band. downlink freq: 3920

Additional Contact:
Susan C. Anderson, 215-351-2653 or 800-523-1546, ext. 2653
E-mail: sanderson@acponline.org

American College of Physicians

Related Lyme Disease Articles from Brightsurf:

Cracking the Lyme disease code
The next time a tick feeds on you, Washington State University researchers hope to make sure persistent arthritis caused by Lyme disease doesn't linger for a lifetime.

Many lyme disease cases go unreported; A new model could help change that
A new model based on 17 years of data can help predict the trajectory of where Lyme disease will spread.

Ethnobotanical medicine is effective against the bacterium causing Lyme disease
A preclinical in vitro study shows that selected plant-based herbal medicines, especially Ghanaian quinine and Japanese knotweed, work better than antibiotics against the bacterium that causes Lyme disease.

Paper-based test could diagnose Lyme disease at early stages
After a day hiking in the forest, the last thing a person wants to discover is a tick burrowing into their skin.

Lyme disease claim lines increased 117% from 2007 to 2018
From 2007 to 2018, claim lines with diagnoses of Lyme disease increased nationally 117%.

New effective vaccines for Lyme disease are coming
There is no effective vaccine currently available to prevent Lyme disease in humans.

New test diagnoses Lyme disease within 15 minutes
Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and requires experienced personnel in a lab, and a few hours to carry out and interpret.

An innovative new diagnostic for Lyme disease
In new research, Joshua LaBaer, executive director of the Biodesign Institute at Arizona State University and his colleagues describe an early detection method for pinpointing molecular signatures of the disease with high accuracy.

Mouse, not just tick: New genome heralds change in Lyme disease fight
As Lyme disease increases, researchers have taken a significant step toward finding new ways to prevent its transmission.

Breakthrough paves way for new Lyme disease treatment
Virginia Tech biochemist Brandon Jutras has discovered the cellular component that contributes to Lyme arthritis, a debilitating and extremely painful condition that is the most common late stage symptom of Lyme disease.

Read More: Lyme Disease News and Lyme Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.